HC Wainwright & Co. Reiterates Buy on Immunocore Hldgs, Maintains $90 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on Immunocore Holdings (NASDAQ:IMCR) and maintained a $90 price target.
March 06, 2024 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirms a Buy rating on Immunocore Holdings with a steady $90 price target.
The reiteration of a Buy rating and maintenance of a high price target by a reputable analyst firm like HC Wainwright & Co. typically signals strong confidence in the company's future performance. This endorsement is likely to positively influence investor sentiment and could lead to a short-term uptick in IMCR's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100